More articles from e-Letters: Observations

Open Access
Retinopathy Outcomes With Empagliflozin Versus Placebo in the EMPA-REG OUTCOME Trial
Silvio E. Inzucchi, Christoph Wanner, Uwe Hehnke, Isabella Zwiener, Stefan Kaspers, Douglas Clark, Jyothis T. George, Bernard Zinman

Diabetes Care Apr 2019, 42 (4) e53-e55; DOI: 10.2337/dc18-1355
Open Access
Glucose Management Indicator (GMI): Insights and Validation Using Guardian 3 and Navigator 2 Sensor Data
Lalantha Leelarathna, Roy W. Beck, Richard M. Bergenstal, Hood Thabit, Roman Hovorka

Diabetes Care Apr 2019, 42 (4) e60-e61; DOI: 10.2337/dc18-2479
Open Access
Detailed Time Course of Decline in Serum C-Peptide Levels in Anti–Programmed Cell Death-1 Therapy–Induced Fulminant Type 1 Diabetes
Daigo Saito, Yoichi Oikawa, Yuya Yano, Yuichi Ikegami, Atsushi Satomura, Masashi Isshiki, Susumu Kurihara, Ikuo Inoue, Mitsuhiko Noda, Akira Shimada

Diabetes Care Mar 2019, 42 (3) e40-e41; DOI: 10.2337/dc18-1673
Open Access
Event Rates and Risk Factors for the Development of Diabetic Ketoacidosis in Adult Patients With Type 1 Diabetes: Analysis From the DPV Registry Based on 46,966 Patients
Hannes Kalscheuer, Jochen Seufert, Stefanie Lanzinger, Joachim Rosenbauer, Wolfram Karges, Dominik Bergis, Julia K. Mader, Stefan Zimny, Sebastian M. Schmid, Michael Hummel, Wolfgang Kerner, Reinhard W. Holl

Diabetes Care Mar 2019, 42 (3) e34-e36; DOI: 10.2337/dc18-1160
Open Access
Center Size and Glycemic Control: An International Study With 504 Centers From Seven Countries
Niels H. Birkebaek, Julia M. Hermann, Lena Hanberger, Dimitrios Charalampopoulos, Reinhard W. Holl, Torild Skrivarhaug, Karin Aakesson, Justin T. Warner, Ann K. Drivvoll, Ann-Marie Svensson, Terence Stephenson, Sabine E. Hofer, Siri Fredheim, Siv J. Kummernes, Rakesh Amin, Birgit Rami-Merhar, Anders Johansen, Thomas M. Kapellen, Doerte Hilgard, Knut Dahl-Jørgensen, Elke Froehlich-Reiterer, Maria Fritsch, Ragnar Hanas, Jannet Svensson

Diabetes Care Mar 2019, 42 (3) e37-e39; DOI: 10.2337/dc18-1253
Open Access
Empagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Left Ventricular Hypertrophy: A Subanalysis of the EMPA-REG OUTCOME Trial
Subodh Verma, C. David Mazer, Deepak L. Bhatt, Satish R. Raj, Andrew T. Yan, Atul Verma, Ele Ferrannini, Gudrun Simons, Jisoo Lee, Bernard Zinman, Jyothis T. George, David Fitchett

Diabetes Care Mar 2019, 42 (3) e42-e44; DOI: 10.2337/dc18-1959
Open Access
Material Need Insecurity and Its Concurrent Barriers to Diabetes Management Among Low-Income Latino Adults Receiving Medical Care
Briga Mullin, Brett S. Cervantes, John Billimek

Diabetes Care Mar 2019, 42 (3) e31-e33; DOI: 10.2337/dc18-1583
Open Access
Incidence Rates of Type 2 Diabetes in People With Impaired Fasting Glucose (ADA vs. WHO Criteria) and Impaired Glucose Tolerance: Results From an Older Population (KORA S4/F4/FF4 Study)
Bernd Kowall, Wolfgang Rathmann, Brenda Bongaerts, Oliver Kuss, Andreas Stang, Michael Roden, Christian Herder, Wolfgang Koenig, Cornelia Huth, Margit Heier, Barbara Thorand, Karl-Heinz Ladwig, Rolf Holle, Christa Meisinger, Annette Peters

Diabetes Care Feb 2019, 42 (2) e18-e20; DOI: 10.2337/dc18-1473
Open Access
Assessing the Association Between GLP-1 Receptor Agonist Use and Diabetic Retinopathy Through the FDA Adverse Event Reporting System
Tiansheng Wang, Wenchao Lu, Huilin Tang, John B. Buse, Til Stürmer, Emily W. Gower

Diabetes Care Feb 2019, 42 (2) e21-e23; DOI: 10.2337/dc18-1893
Open Access
CKD273 Enables Efficient Prediction of Diabetic Nephropathy in Nonalbuminuric Patients
Petra Zürbig, Harald Mischak, Jan Menne, Hermann Haller

Diabetes Care Jan 2019, 42 (1) e4-e5; DOI: 10.2337/dc18-1322

Main menu

User menu

Search

More articles from e-Letters: Observations

Pages

Navigate

More Information

Other ADA Resources